[Combined screening for Down syndrome in Marseille multidisciplinary prenatal centers]
D Ivorra-Deleuze1, F Bretelle, M Heinemann
1Centre de diagnostic prénatal et de médecine fœtale, pôle Mère-Enfant, hôpital Nord, AP-HM, chemin des Bourrely, Marseille, France. ivorra_delphine@yahoo.fr
Gynecologie, Obstetrique & Fertilite
|November 30, 2010
Abstract:
Combined screening for trisomy 21 (CS) is established since January 2010 in multidisciplinary centers for prenatal screening in Marseille. Our work investigates its implementation. To date, the false positive rate is 3.5% and the coverage of the SC after six months is 5.7% in our low-risk population.
Related Concept Videos
01:17Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...